PPH241220P103000
- 0.00
- 0.000.00%
VanEck Pharmaceutical ETF Newsroom
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
Marjorie Taylor Greene Discloses Buys of AMD, Alphabet, Microsoft, Others
PTC Therapeutics Signs Exclusive Global License And Collaboration Agreement With Novartis; PTC To Receive Upfront Payment Of $1B, Up To $1.9B In Development, Regulatory And Sales Milestones
The strongest competitor's data is not good, will the 'weight-loss duo' continue to dominate?
Analysts believe that if Amgen's weight loss drug could achieve a 20% weight loss effect a few years ago, it would have been the best among similar products, but now Eli Lilly and Co and Novo-Nordisk A/S pipeline drugs may achieve or exceed a 25% weight loss effect. Currently, dozens of pharmaceutical companies are actively entering the weight loss drug market, but none have shown the potential to truly challenge the 'weight loss giants'.
Spotlight on AbbVie: Analyzing the Surge in Options Activity
10 Health Care Stocks With Whale Alerts In Today's Session
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Wedbush Assumes Coverage of Voyager With Outperform Rating
What the Options Market Tells Us About Novo Nordisk
Behind the Scenes of Eli Lilly's Latest Options Trends
Jefferies Financial: Trump's return is bullish for growth stocks, with the top 10 having the greatest upside.
Jefferies financial strategists expect that Trump's re-election as president will encourage investors to continue pursuing growth stocks, suggesting that investors avoid value stocks.
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
This month's US stock hot stocks | Is the third wave of AI investment frenzy coming? Applovin soared 93.97% in the month, palantir surged 58.93%; AI electrical utilities demand surged + excellent performance, VST rose 23.66% this month
As of the close of the U.S. stock market on Wednesday, November 27, the three major U.S. indices continued to reach historical highs this month, with the dow jones industrial average rising 7.08%, marking the largest monthly increase of the year.
The Trump economic team may have internal discord, and the key agenda still needs the "understanding king" to make the final decision!
Analysts state that the Trump team's characterization of the economic policy as 'the opponent team' is almost accurate, and the strong opposition between Besant and Lutnik has been publicly reported.
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
European Commission Approves Products by BeiGene, GSK and Novartis
Novo Nordisk Says Health Canada Approves Wegovy (Semaglutide Injection) To Reduce Risk Of Non-Fatal Myocardial Infarction
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
The European Commission Has Approved Novartis' Kisqali (Ribociclib) In Combination With An Aromatase Inhibitor For The Adjuvant Treatment Of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer At High Risk...
Futu Morning Report | The US stock market party continues! The s&p 500 index has risen for seven consecutive days, setting a new historical high; Federal Reserve meeting minutes: future interest rate cuts will be cautious, and the end of monetary easing i
Market response to Trump's tariff threats: auto stocks wail, the Canadian dollar hits a four-year low, and the Mexican peso plunges nearly 3%; dell technologies drops over 10% after hours, with total net revenue for the third quarter at 24.37 billion USD, below analyst expectations.